In a network metanalysis from 2019, GLP1-Ra (vs. placebo) was shown to significantly reduce non-fatal stroke (OR = 0.88, 95% CI (0.77, 0.99), p = 0.002) [37]. The gene discussed is GLP1R; the disease is Stroke.